Article
Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors.
Journal of virology - 1 Jun 1996
Doyon L, Croteau G, Thibeault D, Poulin F, Pilote L, Lamarre D
Abstract excerpt
Protease inhibitors are potent antiviral agents against human immunodeficiency virus type 1. As with reverse transcriptase inhibitors, however, resistance to protease inhibitors can develop and is attributed to the appearance of mutations in the protease gene. With the substrate analog protease inhibitors BILA 1906 BS and BILA 2185 BS, 350- to 1,500-fold-resistant variants have been selected in vitro and were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
